In March 2025, the company introduced new designs for a immediate-to-customer offering of its Wegovy weight loss drug. The company set up a whole new pharmacy, identified as NovoCare, which would charge clients $499 a month for access to the drug, below 50 percent the price of the drug by other pharmaceutical distribution networks.[53]Novo Nordisk